3-(2,5-dimethoxyphenyl)-N-[[6-(4-fluorophenyl)pyrimidin-4-yl]methyl]-1H-pyrazole-5-carboxamide
C23H20FN5O3 — CID 122262929
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(2,5-dimethoxyphenyl)-N-[[6-(4-fluorophenyl)pyrimidin-4-yl]methyl]-1H-pyrazole-5-carboxamide
3-(2,5-dimethoxyphenyl)-N-[[6-(4-fluorophenyl)pyrimidin-4-yl]methyl]-1H-pyrazole-5-carboxamide (PubChem CID 122262929) has the molecular formula C23H20FN5O3 and a molecular weight of 433.44 g/mol. Its IUPAC name is 3-(2,5-dimethoxyphenyl)-N-[[6-(4-fluorophenyl)pyrimidin-4-yl]methyl]-1H-pyrazole-5-carboxamide.
Molecular Properties
| Compound Name | 3-(2,5-dimethoxyphenyl)-N-[[6-(4-fluorophenyl)pyrimidin-4-yl]methyl]-1H-pyrazole-5-carboxamide |
|---|---|
| PubChem CID | 122262929 |
| Molecular Formula | C23H20FN5O3 |
| Molecular Weight | 433.44 g/mol |
| Exact Mass | 433.16 |
| IUPAC Name | 3-(2,5-dimethoxyphenyl)-N-[[6-(4-fluorophenyl)pyrimidin-4-yl]methyl]-1H-pyrazole-5-carboxamide |
| SMILES | COc1ccc(OC)c(-c2cc(C(=O)NCc3cc(-c4ccc(F)cc4)ncn3)[nH]n2)c1 |
| InChI | InChI=1S/C23H20FN5O3/c1-31-17-7-8-22(32-2)18(10-17)20-11-21(29-28-20)23(30)25-12-16-9-19(27-13-26-16)14-3-5-15(24)6-4-14/h3-11,13H,12H2,1-2H3,(H,25,30)(H,28,29) |
| InChIKey | NWRVCFODLSMJEV-UHFFFAOYSA-N |
| XLogP | 3.62 |
| TPSA | 102.02 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 433.44 |
| LogP ≤ 5 | 3.62 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122262929 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.